Investing in high blood pressure research: a national institutes of health perspective.
Investing in high blood pressure research: a national institutes of health perspective.
复制标题
DOI:
10.1161/hypertensionaha.111.00770
复制
发表时间:
2013-04
期刊:
影响因子:
--
通讯作者:
Oh YS
中科院分区:
文献类型:
--
作者:
Galis ZS;Thrasher T;Reid DM;Stanley DV;Oh YS
The publicly available NIH Research Portfolio Online Reporting Tools (RePORT) provide access to estimates of annual NIH funding for various research, condition, and disease categories based on the Research, Condition, and Disease Categorization database. 12 Research Portfolio Online Reporting Tools is helpful in informing the US Congress, the general public, and the research community about the scope and size of NIH investments in specific diseases. Using this tool, we analyzed the Research, Condition, and Disease Categorization funding information for the category HTN for fiscal year (FY) 2011. The total value of the current NIH investment in HTN research was estimated at $240 million. Several NIH Institutes and Centers (IC) sponsor HTN-related awards within their respective areas of interest. The relation between major NIH-sponsored research topics and their various IC can be surveyed in real time using a new online tool called the NIH Map Viewer, 13 which allows distillation of information down to the level of individual awards. The landscape of HTN-related research at the time of this report is illustrated in Figure S1 in the online-only Data Supplement. Among the NIH Institutes in FY2011, the NHLBI sponsored the great majority of HTN research